Lymphocyte Count and Body Mass Index as Biomarkers of Early Treatment Response in a Multiple Sclerosis Dimethyl Fumarate-Treated Cohort

Introduction: In relapsing Multiple Sclerosis (RMS) patients treated with disease modifying drugs (DMDs), few data are available regarding the biomarkers of treatment response. We aimed to assess the predictive value of lymphocyte count (LC) and Body Mass Index (BMI) for treatment response in a real...

Descripción completa

Detalles Bibliográficos
Autores principales: Manni, Alessia, Iaffaldano, Antonio, Lucisano, Giuseppe, D'Onghia, Mariangela, Mezzapesa, Domenico Maria, Felica, Vincenzo, Iaffaldano, Pietro, Trojano, Maria, Paolicelli, Damiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587065/
https://www.ncbi.nlm.nih.gov/pubmed/31258529
http://dx.doi.org/10.3389/fimmu.2019.01343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587065/
https://www.ncbi.nlm.nih.gov/pubmed/31258529
http://dx.doi.org/10.3389/fimmu.2019.01343

Ejemplares similares